<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
  <channel>
    <title>OAR@UM Collection:</title>
    <link>https://www.um.edu.mt/library/oar/handle/123456789/63608</link>
    <description />
    <pubDate>Sat, 25 Apr 2026 20:34:46 GMT</pubDate>
    <dc:date>2026-04-25T20:34:46Z</dc:date>
    <item>
      <title>Proteomic detection of globin gene expression nuclear factors : implementation of an HPLC-CE two-dimensional separation system.</title>
      <link>https://www.um.edu.mt/library/oar/handle/123456789/42357</link>
      <description>Title: Proteomic detection of globin gene expression nuclear factors : implementation of an HPLC-CE two-dimensional separation system.
Abstract: Proteomics is one of the fastest growing fields in the life sciences. The current&#xD;
method of choice for studying the proteome of a cell is two-dimensional gel&#xD;
electrophoresis followed by mass spectrometric analysis of tryptic fragments after in-gel&#xD;
digestion of the protein spots. Although this method is used extensively in proteomics, it&#xD;
does exhibit various shortcomings, where nuclear proteins are tough to separate with this&#xD;
system, primarily owing to their low abundance at their natural cellular concentrations.&#xD;
In order to address such shortcomings the focus of proteomics is shifting towards the&#xD;
implementation of a highly sensitive multidimensional high-pressure liquid&#xD;
chromatography - capillary electrophoresis system Yet, to date no documentation&#xD;
regarding nuclear protein separations using this system was submitted.&#xD;
The addition of hydroxyurea to a K562 cell culture induces their differentiation to&#xD;
erythroid-specific cells, with the consequent synthesis heme, indicative of globin chain&#xD;
synthesis. At 96 hours of incubation a maximum number of cells synthesizing heme&#xD;
were observed, as detected by the benzidine-oxidation test. Nuclear extracts from&#xD;
induced and non-induced K562 cells were injected into the ion-exchange HPLC&#xD;
separation unit. This represented the first dimension separation based on the specific&#xD;
isoelectric points of the nuclear proteins, including erythroid Kruppel-like factor (pI&#xD;
6.71), fetal Kruppel-like factor 1 (pI 8.45) and fetal Kruppel-like factor 2 (pI 9.99). An&#xD;
average of three protein zones, detected as peaks along the elution profile, were eluted&#xD;
from this separation. These protein zones were collected as fractions and injected into a&#xD;
capillary zone electrophoresis system. This second dimension separation yielded a&#xD;
number of protein zones present within the nucleus at the %-hour incubation time.&#xD;
Marked differences in profiles were observed between the non-induced and hydroxyurea-induced&#xD;
K562 cells.&#xD;
The difference in profiles was significant of the "switching on" and "off' of the&#xD;
various genes during the differentiation process resulting in the synthesis of globin&#xD;
chains. The HPLC-CE two-dimensional separation procedure was employed to construct&#xD;
a protein zone map for human erythroid blast-forming-unit (BFU-E) nuclear extracts,&#xD;
which were treated with stem cell factor (another known fetal hemoglobin synthesis&#xD;
inducer in erythroid-lineage cells). Again marked differences were observed between the&#xD;
treated and untreated (control) BFU-E's, indicative of the activation and silencing of&#xD;
genes consequent to differentiation followed by heme synthesis and its incorporation into&#xD;
globin chains.&#xD;
In conclusion, good separations were observed with both the K562 cell nuclear&#xD;
extracts and particularly the human BFU-E nuclear extracts, possibly owing to the use of&#xD;
wide range of protease inhibitors in the nuclear protein extraction procedure. A final&#xD;
identification system, using contemporary mass spectrometry techniques coupled with the&#xD;
HPLC-CE system, can provide the basis for elucidation of the nuclear proteome, thus&#xD;
allowing the targeting of significant proteins in gene expression, as therapeutic drug&#xD;
targets, not only for the hemoglobinopathies described within, but also for the many&#xD;
tissue-specific diseases, such as cancer.
Description: M.SC.BIOMED.SCI.</description>
      <pubDate>Wed, 01 Jan 2003 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.um.edu.mt/library/oar/handle/123456789/42357</guid>
      <dc:date>2003-01-01T00:00:00Z</dc:date>
    </item>
  </channel>
</rss>

